The programmability of synthetic cells facilitates their application as drug delivery devices, but on-demand biosynthesis and release of cargo using a tissue-penetrating stimuli remains a challenge. Now, the heat generated from magnetic hyperthermia — a clinically approved anticancer therapy — is used to control the in situ synthesis and release of biomolecules from within synthetic cells.